Posts Tagged ‘drug safety’

  One of the things we hear most is how simple Oracle Argus Safety is to navigate. In the image (click it to enlarge) above, you’ll notice a familiar folder structure in the upper part of the Regulatory Reports screen – it looks just like Windows Explorer and works similarly. It allows you to drill […]

  In our last “cloud fact or fiction” post, we identified several reasons why hosting clinical and pharmacovigilance systems is just as safe as housing them on-premises. In fact, in many cases it could prove to be safer. This week we’ll briefly discuss migrating data to the cloud. 

  Much like the Coding Review screen, the Medical Review screen is functionality in Oracle’s Argus Safety that displays the relevant case in a single central window and allows a medical reviewer to see all of the key data points that he or she would use when assessing the case. 

Now that February is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in January – they’re ranked in order of popularity, with number one being the most viewed piece. 6 Trends In Life Sciences […]

  Throughout 2015, we should continue to see life sciences companies investing in technology to reduce drug and device development costs and time, and more importantly, to improve the safety and efficacy of their products. It’s no longer a choice, but rather a matter of time: life sciences companies need to upgrade their IT solutions […]

It sounds like a funny topic, but it’s actually an unfortunate problem for many people – one in three, actually. When people struggle to swallow large pills (tablets and capsules), they tend to take less than the prescribed dose, or even avoid taking the medicine altogether. Either situation can result in making their medical conditions […]

Just kidding. You may have read the story on TMZ of a New York businessman making big bucks off the panic surrounding Ebola. Guess what? The FDA hit him where it hurts. His site is down. Stop trying to trick the public. Stop being sleazy. That’s the message the FDA is sending to pharmaceutical, medical […]

The life sciences industry is one of the most heavily regulated in the world, which can make it a frustrating space to do business. But, retracing the current mass of regulations back to their roots can be like the spoonful of sugar that makes the medicine go down…and might even make you feel kinda good […]

The pharmaceutical and medical device industries continue to be under close scrutiny by the FDA when it comes to product safety and the reporting of adverse events. With stringent regulatory requirements that’ll make any company or patient cringe, there’s no way to hide from authorities. And, rightly so. But, guess what? There are also adverse […]

Over the years we have seen some general confusion regarding the use of the FDA MedWatch 7-day report for fatal blood collection or transfusion reporting versus the standard 7-day alert requirement for FDA individual case safety reports from IND trials. Some of the safety systems that our company has worked with over the years do […]

It’s no secret that validation can be a bear. All of that documentation and testing, the multiple phases with pesky transition gates, a million reviews and approvals…it can really slow down an IT project, which often leads to questions about why on Earth we bother with it. Well, it all traces back to rules and regulations […]

The other day, I was watching Cory Johnson interview Bryson Koehler, CTO and CIO of The Weather Company, on Bloomberg West. While the talk focused on The Weather Company’s business model, I thought several points during the discussion were quite relevant to life sciences companies. Frankly, they’re applicable to most industries. The Weather Channel, which […]